CACCIATORE, Ivana
 Distribuzione geografica
Continente #
NA - Nord America 8.449
EU - Europa 6.027
AS - Asia 5.131
SA - Sud America 555
Continente sconosciuto - Info sul continente non disponibili 504
AF - Africa 71
OC - Oceania 4
Totale 20.741
Nazione #
US - Stati Uniti d'America 8.236
SG - Singapore 2.062
IT - Italia 1.394
CN - Cina 1.371
RU - Federazione Russa 1.147
IE - Irlanda 679
UA - Ucraina 553
VN - Vietnam 535
SE - Svezia 503
GB - Regno Unito 490
BR - Brasile 422
TR - Turchia 420
DE - Germania 393
FR - Francia 389
IN - India 270
FI - Finlandia 168
BD - Bangladesh 142
CA - Canada 104
HK - Hong Kong 97
PL - Polonia 59
MX - Messico 55
JP - Giappone 46
AR - Argentina 44
AT - Austria 39
BE - Belgio 37
NL - Olanda 37
ES - Italia 30
IQ - Iraq 29
KR - Corea 24
CO - Colombia 23
CZ - Repubblica Ceca 23
EC - Ecuador 22
ZA - Sudafrica 21
LT - Lituania 18
GR - Grecia 16
ID - Indonesia 16
IR - Iran 16
PK - Pakistan 16
JM - Giamaica 15
SA - Arabia Saudita 14
CH - Svizzera 12
EG - Egitto 11
MA - Marocco 10
VE - Venezuela 10
CL - Cile 9
IL - Israele 9
JO - Giordania 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
KE - Kenya 8
EU - Europa 7
MY - Malesia 7
NP - Nepal 7
PY - Paraguay 7
UY - Uruguay 7
UZ - Uzbekistan 7
DK - Danimarca 6
PT - Portogallo 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
HN - Honduras 5
PA - Panama 5
PE - Perù 5
PH - Filippine 5
RO - Romania 5
DZ - Algeria 4
NO - Norvegia 4
AU - Australia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GY - Guiana 3
KW - Kuwait 3
LB - Libano 3
NI - Nicaragua 3
SV - El Salvador 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
GT - Guatemala 2
HU - Ungheria 2
KZ - Kazakistan 2
LV - Lettonia 2
NG - Nigeria 2
RS - Serbia 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
HR - Croazia 1
LK - Sri Lanka 1
Totale 20.234
Città #
Singapore 1.563
San Jose 933
Chandler 880
Dublin 671
Jacksonville 649
Ashburn 540
Dallas 359
Beijing 336
Southend 300
Council Bluffs 287
Princeton 272
Chieti 257
Izmir 219
Los Angeles 205
New York 197
Nanjing 193
Santa Clara 183
Ho Chi Minh City 170
The Dalles 164
Dearborn 151
Ann Arbor 147
Munich 138
Wilmington 122
Hanoi 118
Pescara 112
Cambridge 98
Altamura 94
Tongling 88
Hong Kong 84
Rome 77
Boardman 73
Buffalo 72
Nanchang 64
Moscow 63
Columbus 54
Shenyang 50
São Paulo 44
Dong Ket 43
Helsinki 42
Tokyo 42
Warsaw 42
Hefei 41
Denver 40
Tianjin 40
Frankfurt am Main 39
Kunming 39
Orem 39
Redondo Beach 39
Woodbridge 39
Milan 38
Atlanta 37
Brussels 33
Hebei 32
Houston 31
Seattle 31
Chicago 30
Montreal 29
Chennai 28
Jinan 28
Toronto 27
Da Nang 26
Falls Church 26
London 26
Washington 26
Mexico City 24
Nuremberg 24
Phoenix 24
San Francisco 24
Turku 24
Vienna 24
Zhengzhou 23
Brooklyn 22
Manchester 22
Boston 21
Jiaxing 21
Norwalk 21
Seoul 21
Poplar 20
Brno 18
Changsha 18
Grevenbroich 18
Guangzhou 18
Haiphong 18
Augusta 17
Kocaeli 17
Naples 17
Stockholm 17
Johannesburg 16
Amsterdam 15
Ancona 15
Shanghai 15
Brasília 14
Ankara 13
Hangzhou 13
Leawood 13
Ningbo 13
Silvi 13
Teramo 13
Bologna 12
Memphis 12
Totale 11.610
Nome #
A new chromogenic substrate for pantetheine hydrolase and vanin proteins 774
Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro 461
Il cofarmaco ibuprofene-glutatione quale nuovo potenziale agente anti-alzheimer 409
Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases 219
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 205
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 204
2,5-Diketopiperazines as neuroprotective agents 196
Carvacrol reduces adipogenic differentiation by modulating autophagy and ChREBP expression 196
Preparation of boronate derivatives for the treatment of diseases and conditions associated to oxidative stress 194
Modulation of apoptotic cell death and neuroprotective effects of glutathione—L-Dopa codrug against H2O2-induced cellular toxicity 188
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 184
Carvacrol codrugs: A new approach in the antimicrobial plan 184
(R)-α-Lipoyl-Gly-L-Pro-L-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease 176
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 175
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 172
Ameliorative Effects by Hexagonal Boron Nitride Nanoparticles against Beta Amyloid Induced Neurotoxicity 170
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma 170
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 169
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 162
Synthesis of a novel TRH-related sulphonamido peptide 161
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 161
Effect of MRJF4 on C6 glioma cells proliferation and migration 160
(R)-alpha-Lipoic Acid–Gly-L-Pro-L-Glu(OMe)-OMe Codrug as Multifunctional Agent for Neurodegenerative Diseases, with Antioxidant and Neuroprotective Properties 159
A Potent (R)-alpha-bis-lipoyl Derivative Containing 8-Hydroxyquinoline Scaffold: Synthesis and Biological Evaluation of Its Neuroprotective Capabilities in SH-SY5Y Human Neuroblastoma Cells 159
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 159
NSAID Coniugates for the treatment of Alzheimer's Disease 159
Carvacrol prodrugs as novel antimicrobial agents 159
Advances in prodrug design for Parkinson's disease 159
Preparation and characterization of polymeric micelles loaded with a potential anticancer prodrug 158
Carvacrol and its derivatives as antibacterial agents 158
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents 157
N-Acetyl-L-Methionyl-L-Dopa-Methyl Ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity 156
Emerging Effects of Resveratrol Derivatives in Cells Involved in Oral Wound Healing: A Preliminary Study 155
Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells 155
GPE and GPE analogues as promising neuroprotective agents 155
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 149
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 148
Cofarmaci L-Dopa-antiossidanti solforati quali nuovi potenziali agenti anti-Parkinson 148
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 148
Synthesis and antioxidant properties of novel memantine derivatives 146
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 145
Biochemical properties of new synthetic carnosine analogues containing the residue of 2,3-diaminopropionic acid: the effect of N-acetylation 145
Sintesi di trans-2-ammino-5(o 6)-cloro-6(o 5)-idrossi-1-fenil-2,3-diidro-1H-indani quali precursori di derivati a potenziale affinità per i recettori della dopamina 143
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 143
L-dopa co-drugs in nanostructured lipid carriers: A comparative study 143
New pharmacologic tools against Parkinson's disease: L-Dopa-antioxidant codrugs containing the methionine residue 142
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 142
Synthesis of Short Cationic Antimicrobial Peptidomimetics Containing Arginine Analogs 140
Nano-delivery systems based on carvacrol prodrugs and fibrous clays 140
sintesi ed attività di due analoghi del glutatione a conformazione ristretta 139
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 138
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 138
N-(tert-butilossicarbonil)-beta,beta-ciclopentil-cisteina (acetamidometil)-metil estere per la sintesi di nuovi derivati peptidomimetici 138
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 135
Discovery of novel RIP derivatives by alanine scanning for the treatment of S. aureus infections. 135
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 134
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 134
N-(tert)-Butyloxycarbonyl-beta,beta-Cyclopentyl-Cysteine (Acetamidomethyl)-Methyl Ester for Synthesis of Novel Peptidomimetic Derivatives 133
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases 133
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 131
RNAIII Inhibiting Peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections 131
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound. 131
Nanoencapsulation strategies for the delivery of novel bifunctional antioxidant/σ1 selective ligands 130
Anticancer effects of novel NSAIDs derivatives on cultured human glioblastoma cells 130
Synthesis and activity of fluorescent glutathione S-conjugates as novel GST inhibitors 129
Delivery Methods of Camptothecin and Its Hydrosoluble Analogue Irinotecan for Treatment of Colorectal Cancer 129
Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation 128
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 127
Synthesis and evaluation of new endomorphoin analogues modified at the Pro2 residue 127
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 127
Multiple lipid nanoparticles as antimicrobial drug delivery systems 126
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 125
Role of Dietary Supplements in the Management of Parkinson's Disease 125
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 125
Anti-Obesity and Anti-Inflammatory Effects of Novel Carvacrol Derivatives on 3T3-L1 and WJ-MSCs Cells 124
Direct- and spacer-coupled codrug strategies for the treatment of Alzheimer’s disease 124
In Vitro Wound-Healing Properties of Water-Soluble Terpenoids Loaded on Halloysite Clay 124
Development of l-Dopa-containing diketopiperazines as blood-brain barrier shuttle 123
From self-Assembly to healing: Engineering ultra-Small peptides into supramolecular hydrogels for controlled drug release 122
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 122
Synthesis and Biological Evaluation of Novel Cinnamic Acid-Based Antimicrobials 122
Carvacrol prodrugs with antimicrobial activity loaded on clay nanocomposites 121
Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate 121
Facile transformation of glutamic acid into proline residue inside a tripeptide backbone 120
Conformationally Constrained Histidines in the Design of Peptidomimetics: Strategies for the χ-Space Control 120
Synthesis and Characterization of Memantine-Loaded Niosomes for Enhanced Alzheimer’s Disease Targeting 120
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation 119
Cytotoxicity and genotoxicity of iron oxide nanoparticles: An in vitro biosafety study 119
Hepatic effects of yttrium oxide nanoflowers: in vitro risk evaluation 119
Structure-Activity relationships of biphalin analogs and their biological evaluation on opioid receptors 118
Antifungal Activity of Novel Formulations Based on Terpenoid Prodrugs against C. albicans in a Mouse Model 118
Dimeric L-dopa derivatives as potential prodrugs. 117
Quorum sensing inhibitor FS3-coated vascular graft enhances daptomycin efficacy in a rat model of staphylococcal infection 117
Histidyl-proline diketopiperazine isomers as multipotent anti-alzheimer drug candidates 117
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential 117
Transition state isosteres of the gamma-glutamyl peptide bond hydrolysis: synthesis and characterization of the psi (CH2NH) pseudopeptide analogue of glutathione 116
Design, synthesis and evaluation of new endomorphin analogues incorporating constrained aminoacids in place of Pro2 residue 115
Neuroinflammation and endoplasmic reticulum stress are coregulated by cyclo(His-Pro) to prevent LPS neurotoxicity 115
Natural oxyprenylated coumarins are modulators of melanogenesis 115
Proline-Glutamate Chimeras in Isopeptides. Synthesis and Biological Evaluation of Conformationally Restricted Glutathione Analogues 113
Totale 15.536
Categoria #
all - tutte 80.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022695 0 0 10 74 88 33 36 50 103 33 70 198
2022/20232.378 177 358 155 258 212 451 114 216 281 47 54 55
2023/20241.295 97 66 72 47 63 409 273 70 20 22 25 131
2024/20253.166 161 584 519 119 42 188 111 177 255 156 354 500
2025/20267.138 544 289 572 803 639 383 1.055 381 1.280 578 357 257
2026/2027967 525 338 104 0 0 0 0 0 0 0 0 0
Totale 20.741